Specialty Pharmacy to Oncology Practice
Patient-specific therapy moved from the dispensing site to the treating practice, timed to the appointment rather than to a carrier's schedule.
Oncology Transport · Statewide California
Oncology Medication Transportation Across California
MedMove moves oncology medications for specialty pharmacies, oncology practices, infusion centers, and qualified healthcare organizations throughout California. Because the shipment may be patient-specific, high-value, temperature-sensitive, or tied to a treatment schedule, it may warrant a dedicated mission with documented custody rather than parcel-network consolidation.
MedMove provides transportation and logistics execution for healthcare organizations. It is not a dispensing pharmacy, does not accept requests from individual patients, and does not make clinical determinations about the medications it carries.
The Operating Problem
An Oncology Shipment Has a Date Attached to It
Most shipments have a delivery window. An oncology shipment has a treatment appointment, an infusion chair reserved, a care team scheduled, and a patient who has arranged their week around it. When the medication is late, the schedule does not simply slip by a day — it has to be rebuilt around the next available slot.
The product itself compounds the problem. Oncology therapies are frequently high-value, frequently patient-specific, and frequently dispensed against a prior authorization that does not regenerate on demand. A shipment that cannot be accounted for is not a claim to file; it is a treatment to reschedule and a conversation the pharmacy has to have with the practice.
MedMove's response to that is narrow and operational: reduce the number of hands the shipment passes through, document each transfer, verify who receives it, and have the exception procedure agreed before it is needed rather than improvised at the destination.
Who This Serves
Organizations Moving Oncology Therapy in California
Specialty pharmacies dispensing oral and injectable oncology therapies
Oncology practices coordinating patient-specific medications
Infusion centers scheduling treatment against delivery windows
Cancer treatment providers and hospital-affiliated oncology programs
Qualified healthcare organizations managing oncology supply movement
Pharmaceutical organizations requiring California transportation
Mission Types
Oncology Transportation Mission Types
Specialty Pharmacy to Infusion Center
Delivery coordinated with the infusion calendar, so product arrives inside the window the center can receive and stage it.
Pharmacy-Initiated Delivery to a Patient
Home delivery where the pharmacy initiates and authorizes the transport, with authorized-recipient verification at the door.
Facility to Facility
Movement between sites of the same organization, or between a central pharmacy and a treating location.
Treatment-Critical Replacement
A replacement shipment moved against a fixed treatment date after a loss, damage, or upstream delivery failure — subject to mission review.
Long-Distance Oncology Routes
Intercity California runs where the treating site is hours from the dispensing pharmacy and consolidation is not acceptable.
Same-day and scheduled missions may be available where route, timing, shipment requirements, and capacity support them. Long California routes are planned as long-distance transportation missions with drive time, thermal duration, and recipient availability settled in advance.
High-Value Cargo Accountability
Documentation That Survives a Question
Direct-drive transportation is the mechanism, not the marketing line. Each additional handoff is a point where possession changes without a named person attached to it. Removing those transfers means that when the pharmacy asks what happened to a shipment, there is a specific answer rather than a network scan.
Temperature-sensitive oncology products move under the requirements the pharmacy or manufacturer sets. How monitoring, documentation, and excursion notification work in practice is covered on the cold-chain transportation page.
Pickup verification against the pharmacy's release documentation
Package-condition documentation at collection and at delivery
Documented chain of custody from pickup through final handoff
Authorized-recipient verification before the handoff completes
Signature capture where the engagement requires it
Delivery confirmation returned to the pharmacy or provider contact
Failed-delivery escalation on pre-agreed contacts and timelines
Return-to-pharmacy and redirection according to client instruction
Scope of Service
What Stays With the Pharmacy or Provider
MedMove executes transportation. The clinical and quality functions belong to the client and are not shared, delegated, or substituted. MedMove does not:
- Dispense, compound, or prescribe medications
- Open, inspect, or repackage medication packaging
- Independently determine medication stability
- Decide whether a medication remains suitable for administration
- Make clinical or treatment decisions
- Replace the pharmacy's quality, clinical, or compliance function
Further Reading
Oncology Medication Delivery Is Risk Management, Not Just Transportation
A longer operational discussion of where oncology delivery risk actually sits — treatment timing, custody gaps, temperature exposure, financial exposure, and what a pharmacy should expect a transport partner to document.
Read the oncology risk-management articleCommon Questions
Oncology Transportation FAQ
- Does MedMove transport oncology medications?
- Yes. MedMove transports oncology medications for specialty pharmacies, oncology practices, infusion centers, and qualified healthcare organizations across California, under the handling requirements the client defines for each shipment.
- Does MedMove dispense or prepare oncology medications?
- No. MedMove provides transportation and logistics execution. It does not dispense, compound, prescribe, open, or repackage medications, and it does not make clinical or product-suitability determinations. Those functions remain with the pharmacy or provider.
- Can MedMove deliver to a patient's home for an oncology pharmacy?
- Yes, when the pharmacy initiates and authorizes that delivery. The request comes from the pharmacy or healthcare organization, never from the patient directly. MedMove verifies the authorized recipient, captures signature where required, and documents the handoff.
- What happens if a delivery to a practice or infusion center cannot be completed?
- The pre-agreed failed-handoff procedure governs. Depending on the client's instructions, the shipment may be held for a defined window, redirected to an alternate approved destination, or returned to the originating pharmacy. The client contact is notified and the outcome is documented.
- Can MedMove move a replacement shipment against a treatment date?
- Treatment-critical replacement transportation is one of the mission types MedMove reviews. Acceptance depends on distance, timing, driver availability, and shipment requirements — each request is assessed before it is confirmed rather than accepted automatically.
- Does MedMove hold certification for hazardous or cytotoxic drug handling?
- MedMove does not represent itself as holding cytotoxic, chemotherapy-specific, or dangerous-goods certification. Shipments are transported in the packaging and under the handling instructions provided or approved by the pharmacy, manufacturer, or client. Requirements that fall outside that scope should be raised during route assessment.
Start Here
Discuss an Oncology Route
Bring a recurring lane, a single dedicated mission, or a replacement shipment that has to reach a treatment date. MedMove will review it and say what it can support.
Or submit the full route assessment form. For healthcare organizations only — do not submit patient information.